Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Therapeutische Umschau. Revue Therapeutique|June 25, 2019
[Neoadjuvant, adjuvant and palliative systemic therapy of colorectal cancer]Michèle Voegeli, Andreas WickiJournal for Immunotherapy of Cancer|March 17, 2016
Systemic inflammation in a melanoma patient treated with immune checkpoint inhibitors-an autopsy studyViktor H Koelzer, Sacha I Rothschild, Deborah Zihler, et al.Hematological Oncology|September 29, 2016
Y90 -Ibritumomab tiuxetan (Y90 -IT) and high-dose melphalan as conditioning regimen before autologous stem cell transplantation for elderly patients with lymphoma in relapse or resistant to chemotherapy: a feasibility trial (SAKK 37/05)Michèle Voegeli, Stephanie Rondeau, Simona Berardi Vilei, et al.International Journal of Molecular Sciences|October 26, 2024
Precision Oncology in Older Cancer Patients: A Single-Center ExperienceMeret Petitat-Berli, Marie Knufinke, Michèle Voegeli, et al.Eclinicalmedicine|October 2, 2023
Combined therapy with ibrutinib and bortezomib followed by ibrutinib maintenance in relapsed or refractory mantle cell lymphoma and high-risk features: a phase 1/2 trial of the European MCL network (SAKK 36/13)Urban Novak, Martin Fehr, Sämi Schär, et al.Blood Advances|January 30, 2025
Six-month rituximab-lenalidomide regimen in advanced untreated follicular lymphoma: SAKK 35/10 trial 10-year updateEva Kimby, Sämi Schär, Maria Cristina Pirosa, et al.Pageof 1